沙特人群游离轻链与免疫球蛋白参考区间的建立
研究纳入180名健康沙特成年人,按IFCC全球方案建立血清游离κ、λ轻链、FLCR及免疫球蛋白的参考区间。新游离κ和FLCR参考区间较厂家区间上移,除IgM外无需性别分组,且BMI、吸烟和运动非变异来源。
要点
- 建立了沙特人群游离轻链和免疫球蛋白的本地参考区间。
- 新游离κ和FLCR参考区间较厂家区间偏向高值侧。
- 除IgM外,其他分析物无需按性别分区参考区间。
核心结论
- 本地建立的沙特人群游离轻链和免疫球蛋白参考区间比厂家或其他国家提供的区间更可靠。
研究设计与样本
- 研究纳入180名健康沙特成年人,采用Binding Site的Freelite试剂检测血清样本。
- 按IFCC全球方案进行参考区间研究,用ANOVA以标准差比(SDR)评估性别、年龄、BMI和地区的变异。
主要发现
- 新游离κ和FLCR参考区间较厂家适配区间偏向高值侧。
- 基于SDR截止值(>0.4),除IgM外所有分析物无需性别分区参考区间。
- 用无多发性骨髓瘤的低丙种球蛋白血症或高丙种球蛋白血症患者样本验证,均在新参考区间内。
- BMI、吸烟和运动不是任何分析物的相关变异来源。
关键数值与推荐
- SDR截止值>0.4用于判断是否需要性别分区参考区间,除IgM外均无需分区。
临床怎么用
- 沙特患者应使用本地建立的参考区间进行游离轻链和免疫球蛋白的临床分类和疾病进展预测。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Testing of serum-free light chains kappa (κ) and lambda (λ), along with ratio (FLCR) is essential for the diagnosis and management of monoclonal gammopathies. Accurate clinical diagnosis depends upon appropriate local population reference intervals (RIs). This study examined the Saudi population for serum-free light chains and other immunoglobulins to establish RIs and to explore variations in the test results by using the International Federation for Clinical Chemistry and Laboratory Medicine's global protocol for harmonized implementation of RI study. METHODS: A total of 180 healthy Saudi adults were recruited. All serum samples were assayed using the Freelite reagents from the Binding Site. The variation in reference values attributable to sex, age, BMI, and region was calculated by ANOVA as a standard deviation ratio (SDR). The RIs for the FLCR were derived by the parametric method and validated by using samples from patients with hypo- and hypergammaglobulinemia. RESULTS: The new RIs for free κ and FLCR were shifted to a higher side from the manufacturer-adapted RIs. Based on the SDR cutoff value (>0.4), between-sex partition RIs were not required for all analytes except IgM. Validation using patients with hypo- or hypergammaglobulinemia and without multiple myeloma, was all within the new RI. BMI, smoking, and exercise were not relevant sources of variation for any analyte. CONCLUSIONS: Locally derived RIs for free light chains and immunoglobulins analytes specific for Saudis were established after careful consideration of various factors. These RIs were more reliable than those provided as guidance by the manufacturer, or from other countries, for appropriate classification and prediction of disease progression for Saudi patients.
引用
- Borai A, Ichihara K, Tamimi W, et al. Establishment of reference intervals for free light chains and immunoglobulins in Saudi population. Clin Chem Lab Med. 2023. PMID: 37787915. doi:10.1515/cclm-2023-0774
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。